Reaction Details |
| Report a problem with these data |
Target | Tyrosine-protein kinase Lck |
---|
Ligand | BDBM50120109 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_96910 |
---|
IC50 | 3±n/a nM |
---|
Citation | Chen, P; Iwanowicz, EJ; Norris, D; Gu, HH; Lin, J; Moquin, RV; Das, J; Wityak, J; Spergel, SH; de Fex, H; Pang, S; Pitt, S; Shen, DR; Schieven, GL; Barrish, JC Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potency. Bioorg Med Chem Lett12:3153-6 (2002) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Tyrosine-protein kinase Lck |
---|
Name: | Tyrosine-protein kinase Lck |
Synonyms: | 2.7.10.2 | LCK | LCK_HUMAN | LSK | Leukocyte C-terminal Src kinase | Lymphocyte cell-specific protein-tyrosine kinase | Lymphocyte-specific protein tyrosine kinase | P56-LCK | Protein YT16 | Proto-oncogene Lck | Proto-oncogene tyrosine-protein kinase LCK | Src/Lck kinase | T cell-specific protein-tyrosine kinase |
Type: | n/a |
Mol. Mass.: | 57987.83 |
Organism: | Homo sapiens (Human) |
Description: | P06239 |
Residue: | 509 |
Sequence: | MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASP
LQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKAN
SLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKH
YKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEV
PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL
VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY
IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK
SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER
PEDRPTFDYLRSVLEDFFTATEGQYQPQP
|
|
|
BDBM50120109 |
---|
n/a |
---|
Name | BDBM50120109 |
Synonyms: | (2-Chloro-6-methyl-phenyl)-(8-methoxy-imidazo[1,5-a]quinoxalin-4-yl)-amine | CHEMBL86230 | N-(2-chloro-6-methylphenyl)-8-methoxyimidazo[1,5-a]quinoxalin-4-amine |
Type | Small organic molecule |
Emp. Form. | C18H15ClN4O |
Mol. Mass. | 338.791 |
SMILES | COc1ccc2nc(Nc3c(C)cccc3Cl)c3cncn3c2c1 |
Structure |
|